Citigroup Inc 9 Meters Biopharma, Inc. Transaction History

Citigroup Inc

  • $169 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022
BUY
$0.26 - $0.64 $13,443 - $33,092
51,707 Added 286.62%
69,747 $18,000
Q1 2022

May 12, 2022
SELL
$0.52 - $1.0 $21,401 - $41,157
-41,157 Reduced 69.53%
18,040 $11,000
Q4 2021

Feb 10, 2022
BUY
$0.85 - $1.33 $26,964 - $42,191
31,723 Added 115.47%
59,197 $58,000
Q3 2021

Nov 10, 2021
BUY
$1.03 - $1.41 $28,298 - $38,738
27,474 New
27,474 $36,000

Others Institutions Holding NMTR

# of Institutions
3
Shares Held
67.9K
Call Options Held
0
Put Options Held
0
View Full List

About 9 METERS BIOPHARMA, INC.

NMTR Quotes by TradingView
  • Ticker NMTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,955,400
  • Market Cap $259K
  • Description
  • 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...
More about NMTR
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email